Table 3.

Clinicopathologic features of the CC validation set

Variable	Total	NSMP	p53abn
Total	614	416 (67.75%)	198 (32.25%)
Age at diagnosis
< 60 yrs	199 (32.41%)	168 (40.38%)	31 (15.66%)
≥ 60 yrs	415 (67.59%)	248 (59.62%)	167 (84.34%)
Unknown
Histotype
Endometrioid	419 (68.24%)	380 (91.35%)	39 (19.7%)
Non-endometrioid	195 (31.76%)	36 (8.65%)	159 (80.3%)
Unknown
Tumor grade
Low grade (G1–2)	390 (63.52%)	376 (90.38%)	14 (7.07%)
High grade (G3)	199 (32.41%)	38 (9.13%)	161 (81.31%)
Unknown	25 (4.07%)	2 (0.48%)	23 (11.62%)
FIGO stage
I-II	487 (79.32%)	369 (88.7%)	118 (59.6%)
III-IV	127 (20.68%)	47 (11.3%)	80 (40.4%)
Unknown	0	0	0